Neumora logomark
Skip to main content

Matthew K. Fust

Matthew Fust is a board member and advisor to life sciences companies. Mr. Fust was previously executive vice president and chief financial officer of Onyx Pharmaceuticals. Prior to Onyx, Matthew held the position of chief financial officer for Jazz Pharmaceuticals and Perlegen Sciences and before that, was senior vice president and chief financial officer at ALZA Corporation, where he was an executive from 1996 until 2002.

Matthew currently serves on the boards of directors of Atara Biotherapeutics, Crinetics Pharmaceuticals and Ultragenyx Pharmaceutical.

He holds a B.A. from the University of Minnesota and an MBA from the Stanford University Graduate School of Business.